Background: Network meta-analysis (NMA) enables simultaneous comparison of multiple treatments while preserving randomisation. When summarising evidence to inform an economic evaluation, it is important that the analysis accurately reflects the dependency structure within the data, as correlations between outcomes may have implication for estimating the net benefit associated with treatment. A multivariate NMA offers a framework for evaluating multiple treatments across multiple outcome measures while accounting for the correlation structure between outcomes. Methods: The standard NMA model is extended to multiple outcome settings in two stages. In the first stage, information is borrowed across outcomes as well across studies through ...
Organisations such as the National Institute for Health and Care Excellence require the synthesis of...
BackgroundNetwork meta-analysis synthesises data from a number of clinical trials in order to assess...
Model-based meta-analysis (MBMA) is increasingly used in drug development to inform decision making ...
Organisations such as the National Institute for Health and Care Excellence require the synthesis of...
In multivariate network meta‐analysis (NMA), the piecemeal nature of the evidence base means that th...
BACKGROUND Network meta-analysis, a method to synthesise evidence from multiple treatments, has i...
BACKGROUND: Network meta-analysis, a method to synthesise evidence from multiple treatments, has inc...
INTRODUCTION Meta-analysis is a powerful tool to cumulate and summarize the knowledge in a research ...
Standard models for network meta-analysis simultaneously estimate multiple relative treatment effect...
There are often multiple potential interventions to treat a disease; therefore, we need a method for...
There are often multiple potential interventions to treat a disease; therefore, we need a method for...
There are often multiple potential interventions to treat a disease; therefore, we need a method for...
There are often multiple potential interventions to treat a disease; therefore, we need a method for...
Background In the last decade, network meta-analysis of randomized controlled trials has been introd...
Meta-analyses often consider the effect of a treatment on multiple, possibly related outcomes. Typic...
Organisations such as the National Institute for Health and Care Excellence require the synthesis of...
BackgroundNetwork meta-analysis synthesises data from a number of clinical trials in order to assess...
Model-based meta-analysis (MBMA) is increasingly used in drug development to inform decision making ...
Organisations such as the National Institute for Health and Care Excellence require the synthesis of...
In multivariate network meta‐analysis (NMA), the piecemeal nature of the evidence base means that th...
BACKGROUND Network meta-analysis, a method to synthesise evidence from multiple treatments, has i...
BACKGROUND: Network meta-analysis, a method to synthesise evidence from multiple treatments, has inc...
INTRODUCTION Meta-analysis is a powerful tool to cumulate and summarize the knowledge in a research ...
Standard models for network meta-analysis simultaneously estimate multiple relative treatment effect...
There are often multiple potential interventions to treat a disease; therefore, we need a method for...
There are often multiple potential interventions to treat a disease; therefore, we need a method for...
There are often multiple potential interventions to treat a disease; therefore, we need a method for...
There are often multiple potential interventions to treat a disease; therefore, we need a method for...
Background In the last decade, network meta-analysis of randomized controlled trials has been introd...
Meta-analyses often consider the effect of a treatment on multiple, possibly related outcomes. Typic...
Organisations such as the National Institute for Health and Care Excellence require the synthesis of...
BackgroundNetwork meta-analysis synthesises data from a number of clinical trials in order to assess...
Model-based meta-analysis (MBMA) is increasingly used in drug development to inform decision making ...